RFC2 Activators

RFC2 Activators are a class of compounds that can enhance the functional activity of the RFC2 protein. These chemicals primarily act by disrupting DNA replication or repair mechanisms, thereby indirectly increasing the need for RFC2's essential activities. For instance, chemicals like Doxorubicin, Etoposide, Camptothecin, Bleomycin, Cisplatin, and Mitomycin C cause various types of DNA damage, ranging from intercalation to strand breaks and crosslinks. This DNA damage enhances the demand for RFC2's role in DNA repair.

In contrast, agents like Hydroxyurea, Gemcitabine, Fludarabine, and 5-Fluorouracil disrupt DNA synthesis, thereby enhancing the demand for RFC2's role in DNA replication. Caffeine and Olaparib act on specific proteins involved in the DNA damage response (ATM kinase) and DNA repair (PARP), respectively. By disrupting these processes, these chemicals could skew the cell towards other repair mechanisms that involve RFC2, thereby enhancing its function. Consequently, the modus operandi of these chemical activators centers on increasing the cellular demand for RFC2's roles in DNA metabolism, thereby indirectly enhancing its functional activity.